4.7 Review

Immune-Cell-Derived Exosomes for Cancer Therapy

Related references

Note: Only part of the references are listed.
Article Engineering, Biomedical

An efficient and safe MUC1-dendritic cell-derived exosome conjugate vaccine elicits potent cellular and humoral immunity and tumor inhibition in vivo

Haomiao Zhu et al.

Summary: Antitumor vaccines that elicit antitumor immune responses and induce protective immunity against specific antigens on tumor cells are a promising strategy for preventing or treating cancers. In this study, a MUC1 glycopeptide antigen was conjugated to dendritic cell-derived exosomes (Dex) to develop an antitumor vaccine candidate. The results showed that the MUC1-Dex construct induced high levels of specific antibodies and inhibited tumor growth, prolonging survival in tumor-bearing mouse models.

ACTA BIOMATERIALIA (2022)

Article Oncology

M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942

Ke Wei et al.

Summary: The study demonstrates that exosomes derived from M2 macrophages play a role in promoting invasion and migration of LUAD cells through miRNA regulation, providing a new therapeutic target for metastatic LUAD.

CANCER LETTERS (2022)

Review Chemistry, Multidisciplinary

Nanomaterials targeting tumor associated macrophages for cancer immunotherapy

Caiyan Zhao et al.

Summary: TAMs are key players in tumor progression and can be modulated using nanotechnology-based strategies, such as inhibiting their recruitment, depleting M2-polarized macrophages, and reprogramming them into M1-polarized macrophages. Nanoparticles can also be used to image TAMs for novel treatment options and therapy monitoring.

JOURNAL OF CONTROLLED RELEASE (2022)

Review Oncology

Exosomal Proteins and Lipids as Potential Biomarkers for Lung Cancer Diagnosis, Prognosis, and Treatment

Ming-Tsung Hsu et al.

Summary: Exosomes play a crucial role in intercellular communication and can be utilized as valuable tools for the diagnosis and treatment of lung cancer. This review comprehensively analyzes the protein and lipid characteristics of lung cancer-derived exosomes and explores their molecular functions and mechanisms in physiological and pathological processes.

CANCERS (2022)

Article Cell Biology

Exogenous and Endogenous Dendritic Cell-Derived Exosomes: Lessons Learned for Immunotherapy and Disease Pathogenesis

Mahmoud Elashiry et al.

Summary: DC-derived exosomes show favorable safety and tolerance profiles in clinical trials and are widely used in the treatment of inflammatory and neoplastic diseases. These exosomes can be customized for specific immune cell targeting and have the advantages of stability, small size, and rapid uptake. It is important to understand the mechanisms of exosome biogenesis, uptake, routing, and in vivo biodistribution. Furthermore, endogenous exosomes secreted by all cells can contribute to pathological processes such as chronic inflammation and tumorigenesis.

CELLS (2022)

Review Cell Biology

Plasmacytoid Dendritic Cells and Cancer Immunotherapy

Chunmei Fu et al.

Summary: Although clinical trials of dendritic cell-based vaccines have been disappointing, recent studies have shown that cross-priming mediated by dendritic cells plays a critical role in generating anti-tumor immunity. This supports further development of dendritic cell vaccines as immunotherapy. Recent clinical studies have also shown promise with naturally circulating dendritic cells and dendritic cell-derived exosomes as cancer vaccines.

CELLS (2022)

Article Engineering, Biomedical

Mature dendritic cell-derived dendrosomes swallow oxaliplatin-loaded nanoparticles to boost immunogenic chemotherapy and tumor antigen-specific immunotherapy

Xing Chen et al.

Summary: The cytomembrane-derived delivery platform is a promising biomimetic strategy for oncotherapy. By fusing mature dendrosomes with redox-responsive nanoparticles, durable and reliable tumor inhibition can be achieved, along with enhanced immunogenicity and immunocyte differentiation. Combination with aPD-L1 further enhances the antitumor effect.

BIOACTIVE MATERIALS (2022)

Article Cell Biology

M1 macrophage-derived exosomes and their key molecule lncRNA HOTTIP suppress head and neck squamous cell carcinoma progression by upregulating the TLR5/NF-κB pathway

Huaili Jiang et al.

Summary: This study revealed that M1-derived exosomes containing HOTTIP activate the TLR5/NF-kappa B signaling pathway by competitively sponging miR-19a-3p and miR-19b-3p, thereby suppressing the progression of head and neck squamous cell carcinoma (HNSCC). Additionally, M1-derived exosomes and HOTTIP induce the polarization of circulating monocytes towards an M1 phenotype, providing new insights into HNSCC immunotherapy.

CELL DEATH & DISEASE (2022)

Article Multidisciplinary Sciences

Programmable black phosphorus image sensor for broadband optoelectronic edge computing

Seokhyeong Lee et al.

Summary: The authors report the realization of a programmable image sensor based on black phosphorus that can perform multispectral imaging and analog in-memory computing in the near- to mid-infrared range. The sensor enables in-sensor computing, reducing communication latency and power consumption. This multifunctional infrared image sensor has great potential for distributed and remote multispectral sensing applications.

NATURE COMMUNICATIONS (2022)

Article Immunology

Proteomic Profiling and Functional Analysis of B Cell-Derived Exosomes upon Pneumocystis Infection

Dan Ma et al.

Summary: This study investigated exosomes derived from B lymphocytes in response to Pneumocystis pneumonia (PCP) using quantitative proteomics. The results showed that these exosomes play a role in immune response and transcription regulation, and have a proinflammatory effect on CD4(+) T cell response in PCP.

JOURNAL OF IMMUNOLOGY RESEARCH (2022)

Article Cell Biology

T Lymphocyte and CAR-T Cell-Derived Extracellular Vesicles and Their Applications in Cancer Therapy

Victor Calvo et al.

Summary: Extracellular vesicles (EV) are diverse cell-derived vesicles that participate in intercellular communication and cargo delivery. Specific EV released by certain cells can be used for cell-free, EV-dependent cancer therapy.

CELLS (2022)

Review Oncology

Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

M-L Schubert et al.

Summary: CAR T-cell therapy targeting CD19-expressing B cells has shown promising results in treating refractory and/or relapsed B-cell malignancies, but also presents challenges such as cytokine release syndrome and neurotoxicity syndrome. Optimal management strategies for the side-effects associated with CAR T-cell therapy are crucial as it expands into other diseases in hematology and oncology.

ANNALS OF ONCOLOGY (2021)

Review Chemistry, Multidisciplinary

Carrier-free nanodrugs for safe and effective cancer treatment

Sena Karaosmanoglu et al.

Summary: The clinical applications of many anti-cancer drugs are limited by their hydrophobic nature, leading to the development of carrier-based nanoparticles. However, these strategies often fail to efficiently encapsulate drugs and may cause toxicity problems in the long term. Therefore, elegantly designed strategies for carrier-free nanodrugs, including simple self-assembly and chemical modifications, are desired for high quality, stability, and performance.

JOURNAL OF CONTROLLED RELEASE (2021)

Review Chemistry, Multidisciplinary

Challenges in the development and establishment of exosome-based drug delivery systems

Jin Wang et al.

Summary: Exosomes, as potential drug delivery vehicles, have been studied extensively, but face multiple technical challenges, including isolation, characterization, and stability testing, as well as challenges related to drug cell-uptake, loading, release, and in vivo distribution.

JOURNAL OF CONTROLLED RELEASE (2021)

Review Oncology

Exploring the NK cell platform for cancer immunotherapy

Jacob A. Myers et al.

Summary: NK cells have innate potential to kill cancer cells, leading to the development of various NK cell-based therapies for cancer treatment. The main focus of NK cell therapy research is on optimizing sources of therapeutic NK cells and enhancing their cytotoxicity and persistence in the body.

NATURE REVIEWS CLINICAL ONCOLOGY (2021)

Article Engineering, Biomedical

Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy

Li Huang et al.

Summary: Carrier-free nanodrugs, completely formulated with one or more drugs, have shown great potential in cancer therapy by improving pharmacodynamics/pharmacokinetics, reducing toxicity, and increasing drug loading. Utilizing different preparation strategies, these nanodrugs have demonstrated advantages in various therapeutic modalities, which may pave the way for effective treatments in the future.

BIOMATERIALS (2021)

Article Engineering, Biomedical

M1 macrophage exosomes engineered to foster M1 polarization and target the IL-4 receptor inhibit tumor growth by reprogramming tumor-associated macrophages into M1-like macrophages

Gowri Rangaswamy Gunassekaran et al.

Summary: In this study, M1 macrophage-derived exosomes were engineered to reprogram TAMs into M1-like macrophages for inhibiting tumor growth. The results showed that systemic administration of these exosomes increased anti-tumor immunity more efficiently than untargeted and control peptide-labeled exosomes.

BIOMATERIALS (2021)

Review Pharmacology & Pharmacy

The Impact of Immune Cell-derived Exosomes on Immune Response Initiation and Immune System Function

Fataneh Tavasolian et al.

Summary: Exosomes are small extracellular vesicles that play a role in cell-to-cell communication by transferring genetic material. They are involved in various immune system functions such as antigen presentation, NK cell and T cell activation/polarisation, immune suppression, and anti-inflammatory processes. Exosomes have potential applications in immunotherapy as delivery vehicles.

CURRENT PHARMACEUTICAL DESIGN (2021)

Review Biochemistry & Molecular Biology

Exosomes: Cell-Derived Nanoplatforms for the Delivery of Cancer Therapeutics

Hyosuk Kim et al.

Summary: Exosomes are nanovesicles secreted by cells that can mediate intercellular communication and serve as promising drug delivery vehicles due to their stability, biocompatibility, and targeting abilities. They can carry therapeutic signaling molecules from specific cell types, impacting cancer treatment significantly.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Immunology

B cells and cancer: To B or not to B?

Wolf Herman Fridman et al.

Summary: Recent studies have suggested that B cells in the tumor microenvironment may play a significant role in presenting tumor-associated antigens to T cells and producing antibodies that enhance antigen presentation, ultimately impacting cancer clinical outcomes. Immune complexes formed by B cells can also have deleterious effects through inflammation, angiogenesis, and immunosuppression via macrophage and complement activation.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Multidisciplinary Sciences

A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy

Shoichi Iriguchi et al.

Summary: The study presents a feeder-free, scalable differentiation process of human induced pluripotent cells (iPSCs) into T-cells with T-cell receptor dependent anti-tumor function in vitro and in vivo, providing a platform for clinical application and research on human T-cell differentiation and biology.

NATURE COMMUNICATIONS (2021)

Review Oncology

The Interplay of Exosomes and NK Cells in Cancer Biology

Ines A. Batista et al.

Summary: Cancer is the second most common cause of death globally, with an expected rise of about 50% in incidence and mortality in the coming decades. Immunotherapy has shown the best results for cancer treatment, highlighting the importance of studying anti-tumor immune response in cancer research.

CANCERS (2021)

Article Cell Biology

The exosomes derived from CAR-T cell efficiently target mesothelin and reduce triple-negative breast cancer growth

Pengxiang Yang et al.

Summary: Exosomes derived from CAR-T cells targeting MSLN showed potential in inhibiting the growth of MSLN-positive triple-negative breast cancer cells, with characteristics similar to parental T cells. The expression of effector molecules may contribute to tumor killing, and in vivo studies demonstrated a highly effective tumor inhibition rate with no obvious side effects. The use of CAR-T cell exosomes has promising therapeutic potential against MSLN-expressing TNBC.

CELLULAR IMMUNOLOGY (2021)

Review Oncology

The Role of RNA Modifications and RNA-modifying Proteins in Cancer Therapy and Drug Resistance

Shaun Wood et al.

Summary: The use of new genome-wide sequencing technologies has revealed abnormal RNA modifications and RNA editing in various human cancers, with a particular focus on RNA: m(6)A and its associated RNA modifying proteins (RMPs). More research is needed to understand other RNA modifications and RMPs, especially in the context of cancer therapy and drug resistance. Dysregulation of RNA modifications and RMPs in cancer and their impact on cancer treatment and drug resistance are important areas for further study.

CURRENT CANCER DRUG TARGETS (2021)

Article Cell Biology

Role and Function of T Cell-Derived Exosomes and Their Therapeutic Value

Yuanyuan Shao et al.

MEDIATORS OF INFLAMMATION (2021)

Article Medicine, Research & Experimental

Immunotherapy Strategy Targeting Programmed Cell Death Ligand 1 and CD73 with Macrophage-Derived Mimetic Nanovesicles to Treat Bladder Cancer

Qidong Zhou et al.

Summary: The use of EMVs as a nanoplatform for delivering a combination of CD73 inhibitor and aPDL1 monoclonal antibody showed promising results in improving therapeutic effects for bladder cancer.

MOLECULAR PHARMACEUTICS (2021)

Review Chemistry, Multidisciplinary

Chemically Engineered Immune Cell-Derived Microrobots and Biomimetic Nanoparticles: Emerging Biodiagnostic and Therapeutic Tools

Leila Pourtalebi Jahromi et al.

Summary: In recent decades, diverse immune cells have been explored for their potential as therapeutic and diagnostic cell-based microrobots for challenging disorders. These systems leverage the unique characteristics and functions of immune cells to address a variety of diseases.

ADVANCED SCIENCE (2021)

Article Chemistry, Multidisciplinary

On-Chip Biogenesis of Circulating NK Cell-Derived Exosomes in Non-Small Cell Lung Cancer Exhibits Antitumoral Activity

Yoon-Tae Kang et al.

Summary: NK cells and their derived exosomes play a crucial role in cancer immunotherapy, as they exhibit high stability and lower immunogenicity, providing possibilities for personalized treatments. A novel microfluidic system for collecting patient-specific NK cells and NK-exosomes on chips offers potential applications in cancer therapies.

ADVANCED SCIENCE (2021)

Review Oncology

Regulation of Antitumor Immune Responses by Exosomes Derived from Tumor and Immune Cells

Andres Rincon-Riveros et al.

Summary: Extracellular vesicles, such as exosomes, have the potential to serve as biomarkers for cancer development, impacting various aspects of tumor progression and immune regulation.

CANCERS (2021)

Review Cell Biology

Exosome-Based Delivery of Natural Products in Cancer Therapy

Hang Song et al.

Summary: This review provides an overview of the application of exosomes as natural product delivery carriers in cancer therapy, focusing on their composition, biogenesis, and functions in cancer. The advantages and applications of exosomes in drug delivery for cancer therapy, as well as the recent progress and challenges in using exosomes as carriers for natural products in cancer treatment, are discussed in this review.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Review Chemistry, Multidisciplinary

Cell-Based Delivery Systems: Emerging Carriers for Immunotherapy

Zhaoting Li et al.

Summary: Immunotherapy plays a crucial role in treating diseases, but its application is hindered by limited response rates and systemic side effects. Using natural cells as carriers can reduce immunogenicity and toxicity, while controlling their spatiotemporal distribution can enhance treatment efficacy and minimize side effects.

ADVANCED FUNCTIONAL MATERIALS (2021)

Article Veterinary Sciences

M1 and M2 tumour-associated macrophages subsets in canine malignant mammary tumours: An immunohistochemical study

Francesca Parisi et al.

Summary: This study quantified TAMs in 60 canine malignant mammary tumors and found that the presence of M2-polarized TAMs was associated with tumor development and disease progression. CD204 expression may serve as a potential prognostic factor for these tumors.

RESEARCH IN VETERINARY SCIENCE (2021)

Article Cell Biology

M2 macrophage-derived exosomal long non-coding RNA AGAP2-AS1 enhances radiotherapy immunity in lung cancer by reducing microRNA-296 and elevating NOTCH2

Fuquan Zhang et al.

Summary: The study revealed that AGAP2-AS1 was increased in radioresistant patients and lung cancer cells, while miR-296 showed a decreasing trend. Inhibiting AGAP2-AS1 helped promote the malignant phenotypes of radioresistant lung cancer cells. The results suggested that AGAP2-AS1 negatively regulated miR-296, thereby upregulating NOTCH2 and enhancing radiotherapy immunity in lung cancer.

CELL DEATH & DISEASE (2021)

Article Oncology

Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer

Kuebra Kaban et al.

Summary: The overexpression of antiapoptotic protein BCL-2 is linked with ER expression in breast cancer, and a novel treatment strategy using NK cell-derived exosomes as carriers for BCL-2 targeted siRNAs has been proposed. This approach has shown to enhance the killing ability of NK cell-derived exosomes by silencing BCL-2 overexpression and targeting oncogenes in breast cancer.

CANCERS (2021)

Article Nanoscience & Nanotechnology

Engineering Exosomes Endowed with Targeted Delivery of Triptolide for Malignant Melanoma Therapy

Liangdi Jiang et al.

Summary: The study proposes a delivery system based on TRAIL-engineered exosomes (TRAIL-Exo) for loading TPL for targeted therapy against malignant melanoma, which improves tumor targetability, enhances cellular uptake, inhibits proliferation, invasion, and migration, and induces apoptosis of A375 cells through activating the extrinsic TRAIL pathway and the intrinsic mitochondrial pathway in vitro. Intravenous injection of TRAIL-Exo/TPL significantly suppresses tumor progression and reduces the toxicity of TPL in the melanoma nude mouse model, presenting a novel strategy for high-efficiency exosome-based drug-delivery nanocarriers with synergistic therapeutic efficacy and targeting capacity for melanoma treatment.

ACS APPLIED MATERIALS & INTERFACES (2021)

Review Pharmacology & Pharmacy

Natural killer (NK) cell-based immunotherapies and the many faces of NK cell memory: A look into how nanoparticles enhance NK cell activity

Idoia Mikelez-Alonso et al.

Summary: NK cells are lymphocytes with potent antitumor and antiviral functions, exhibiting memory-like responses. Various NK cell-based immunotherapies have been developed, with nanotechnology considered as an attractive option to enhance NK cell effector functions.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Chemistry, Multidisciplinary

Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy

Zhaoting Li et al.

Summary: Bacteria, with their intrinsic biocompatibility and motility, have been utilized as an emerging delivery system in various biomedical applications, drawing wide interest in the diagnosis and treatment of diseases. The synergy of chemical biotechnology and bacteria has opened up many research opportunities, creating a promising frontier in biomedical applications. Research on bacteria-based delivery systems is focusing on emerging advances in diagnosis and therapy, bringing new possibilities to the field.

ADVANCED MATERIALS (2021)

Article Chemistry, Multidisciplinary

T-Cell-Derived Nanovesicles for Cancer Immunotherapy

Jihye Hong et al.

Summary: While T-cell therapy is a significant breakthrough in cancer immunotherapy, its efficacy against solid tumors is limited due to T-cell exhaustion caused by immunosuppressive mechanisms. T-cell-derived nanovesicles (TCNVs) produced by extrusion through membranes with micro/nanosized pores show promising anti-tumoral activity in the immunosuppressive tumor microenvironment. TCNVs express programmed cell death protein 1 and TGF-beta receptor on their surface, which helps block PD-L1 on cancer cells and scavenge TGF-beta in the TME, preventing T-cell exhaustion and directly killing cancer cells. These findings suggest TCNVs as an effective strategy for cancer immunotherapy to overcome tumor's immunosuppressive mechanisms.

ADVANCED MATERIALS (2021)

Article Endocrinology & Metabolism

M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt/GSK-3β/β-catenin pathway in mice

Bin Qian et al.

Summary: This study revealed that M1-polarized macrophages are enriched in the islets of obese mice and can impair beta cell insulin secretion through exosome-mediated communication, with miR-212-5p playing a key role in this process. The findings suggest that M1 macrophage-derived exosomes regulate sirtuin 2 gene through miR-212-5p, leading to restricted insulin secretion in recipient beta cells.

DIABETOLOGIA (2021)

Review Cell Biology

The effect of immune cell-derived exosomes in the cardiac tissue repair after myocardial infarction: Molecular mechanisms and pre-clinical evidence

Heling Wen et al.

Summary: Inflammatory responses play a crucial role in repair after myocardial infarction, but excessive inflammation may lead to abnormal cardiac remodeling and heart failure. Modulating immune responses and using exosomes as mediators can improve the repair process of infarcted myocardium and maintain ventricular function. Further research on the role of exosomes secreted by different immune cells in infarcted myocardium post-MI is needed to develop future therapeutic strategies for MI patients.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Multidisciplinary Sciences

The macrophage odorant receptor Olfr78 mediates the lactate-induced M2 phenotype of tumor-associated macrophages

Sri Murugan Poongkavithai Vadevoo et al.

Summary: The study suggests that Olfr78 can sense tumor-derived lactate and, in conjunction with Gpr132, mediate the generation of protumoral M2-TAMs. The interaction between Olfr78 and lactate may serve as a therapeutic target for reducing tumor progression and metastasis.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)

Review Immunology

Natural Killer Cell-Derived Extracellular Vesicles: Novel Players in Cancer Immunotherapy

Feifeng Wu et al.

Summary: NK cell-derived EVs play a crucial role in antitumor immunity by killing tumor cells through various mechanisms, as well as modulating immunity and immune surveillance. They have potential applications in cancer immunotherapy.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

DC-Derived Exosomes for Cancer Immunotherapy

Yi Yao et al.

Summary: Dendritic cells (DCs)-based cancer vaccines have not been very successful due to tumor-mediated immunosuppression, leading to limited clinical efficacy. DC-derived exosomes (DCexos) are considered as a promising alternative to DC-based vaccines, as they are more resistant to tumor-mediated suppression and have shown better anti-tumor efficacy in pre-clinical models.

CANCERS (2021)

Article Pharmacology & Pharmacy

M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer

Yongmei Zhao et al.

Summary: This study developed a specific drug delivery system based on M1 macrophage-derived exosomes for pancreatic cancer with chemoresistance. The nanoformulation combining GEM and DFX in M1Exo significantly enhanced therapeutic efficacy against GEM-resistant cancer cells.

PHARMACEUTICS (2021)

Article Nanoscience & Nanotechnology

Macrophage-Derived Exosomal miR-31-5p Promotes Oral Squamous Cell Carcinoma Tumourigenesis Through the Large Tumor Suppressor 2-Mediated Hippo Signalling Pathway

Yi Yuan et al.

Summary: This study showed that M2 macrophage-derived exosomal miR31-5p can inhibit the tumor suppressor LATS2 gene and promote OSCC progression by suppressing the Hippo signaling pathway, potentially providing new targets for molecular therapy of OSCC.

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2021)

Review Medicine, Research & Experimental

The pivotal roles of exosomes derived from endogenous immune cells and exogenous stem cells in myocardial repair after acute myocardial infarction

Yu-Yan Xiong et al.

Summary: AMI is a leading cause of mortality globally, with inflammatory response playing a pivotal role in myocardial necrosis and ventricular remodeling. Exosomes, containing biologically active substances, have emerged as key players in immune regulation post AMI, alongside a variety of immune cells working together for tissue cleanup and repair. Research into exosomes from both endogenous immune cells and exogenous stem cells has shown promising therapeutic effects in immunomodulation for myocardial repair post AMI.

THERANOSTICS (2021)

Article Medicine, Research & Experimental

CD45RO(-)CD8(+) T cell-derived exosomes restrict estrogen-driven endometrial cancer development via the ER beta/miR-765/PLP2/Notch axis

Wen-Jie Zhou et al.

Summary: The study investigated the molecular mechanisms underlying the interaction between estrogen signaling and CD8(+) T cells, and identified the regulatory value of the ER beta/miR-765/PLP2/Notch signaling axis in uterine corpus endometrial cancer.

THERANOSTICS (2021)

Article Multidisciplinary Sciences

B cells are associated with survival and immunotherapy response in sarcoma

Florent Petitprez et al.

NATURE (2020)

Article Multidisciplinary Sciences

B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink et al.

NATURE (2020)

Review Biotechnology & Applied Microbiology

NK cells for cancer immunotherapy

Noriko Shimasaki et al.

NATURE REVIEWS DRUG DISCOVERY (2020)

Review Multidisciplinary Sciences

The biology, function, and biomedical applications of exosomes

Raghu Kalluri et al.

SCIENCE (2020)

Review Cell Biology

miRNAs in NK Cell-Based Immune Responses and Cancer Immunotherapy

Silvia Pesce et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Article Biotechnology & Applied Microbiology

Isolation and characterization of canine natural killer cell-derived exosomes

J. Lee et al.

CYTOTHERAPY (2020)

Review Biochemistry & Molecular Biology

Mechanisms of Multidrug Resistance in Cancer Chemotherapy

Karol Bukowski et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Review Medicine, Research & Experimental

Exosomes as drug carriers for cancer therapy and challenges regarding exosome uptake

Xiaoyin Zhao et al.

BIOMEDICINE & PHARMACOTHERAPY (2020)

Review Nanoscience & Nanotechnology

Exosomes as Actively Targeted Nanocarriers for Cancer Therapy

Yan Wang et al.

INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)

Review Oncology

Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors

Lorenzo Galluzzi et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Review Oncology

Exosome as a Natural Gene Delivery Vector for Cancer Treatment

Prasad Pofali et al.

CURRENT CANCER DRUG TARGETS (2020)

Review Oncology

Dendritic cell biology and its role in tumor immunotherapy

Yingying Wang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

Article Cell Biology

Immune (Cell) Derived Exosome Mimetics (IDEM) as a Treatment for Ovarian Cancer

Simone Pisano et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)

Review Environmental Sciences

Exosome engineering: Current progress in cargo loading and targeted delivery

Shengyang Fu et al.

NANOIMPACT (2020)

Review Chemistry, Medicinal

Exosomes from different cells: Characteristics, modifications, and therapeutic applications

Mingyuan Li et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

Review Biochemistry & Molecular Biology

Exosome-based immunotherapy: a promising approach for cancer treatment

Zhijie Xu et al.

MOLECULAR CANCER (2020)

Review Oncology

Nanoparticulate RNA delivery systems in cancer

Ankur Sharma et al.

CANCER REPORTS (2020)

Review Materials Science, Biomaterials

Exosome: a significant nano-scale drug delivery carrier

Huan Peng et al.

JOURNAL OF MATERIALS CHEMISTRY B (2020)

Review Oncology

Role of RNA modifications in cancer

Isaia Barbieri et al.

NATURE REVIEWS CANCER (2020)

Review Oncology

Immune Cell-Derived Exosomes in the Cancer-Immunity Cycle

Wei Yan et al.

TRENDS IN CANCER (2020)

Review Biochemistry & Molecular Biology

Exosomes: key players in cancer and potential therapeutic strategy

Jie Dai et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Medicine, Research & Experimental

Clinical applications of exosome membrane proteins

Qian Hu et al.

PRECISION CLINICAL MEDICINE (2020)

Review Biochemistry & Molecular Biology

Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells

Mohamed-Reda Benmebarek et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Review Biochemistry & Molecular Biology

Immune Cell-Derived Extracellular Vesicles - Functions and Therapeutic Applications

Rosanne E. Veerman et al.

TRENDS IN MOLECULAR MEDICINE (2019)

Review Chemistry, Multidisciplinary

Theranostic Nanoparticles for RNA-Based Cancer Treatment

Richard A. Revia et al.

ACCOUNTS OF CHEMICAL RESEARCH (2019)

Article Engineering, Biomedical

Macrophage-derived exosome-mimetic hybrid vesicles for tumor targeted drug delivery

Sagar Rayamajhi et al.

ACTA BIOMATERIALIA (2019)

Review Allergy

B-cell responses in allergen immunotherapy

Pattraporn Satitsuksanoa et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Review Chemistry, Multidisciplinary

Developing Protein-Based Nanoparticles as Versatile Delivery Systems for Cancer Therapy and Imaging

Febrina Sandra et al.

NANOMATERIALS (2019)

Review Oncology

The TRAIL to cancer therapy: Hindrances and potential solutions

Sonia How Ming Wong et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2019)

Review Pharmacology & Pharmacy

Carrier-free nanodrug: A novel strategy of cancer diagnosis and synergistic therapy

Ming-Yue Yang et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)

Article Multidisciplinary Sciences

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity

Wenyan Fu et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy

Tuying Yong et al.

NATURE COMMUNICATIONS (2019)

Article Chemistry, Multidisciplinary

The Crown and the Scepter: Roles of the Protein Corona in Nanomedicine

Rong Cai et al.

ADVANCED MATERIALS (2019)

Review Medicine, Research & Experimental

Exosome as a Novel Shuttle for Delivery of Therapeutics across Biological Barriers

Chandan Kanta Das et al.

MOLECULAR PHARMACEUTICS (2019)

Review Biotechnology & Applied Microbiology

Delivery technologies for cancer immunotherapy

Rachel S. Riley et al.

NATURE REVIEWS DRUG DISCOVERY (2019)

Article Chemistry, Multidisciplinary

A Label-Free Platform for Identification of Exosomes from Different Sources

Zhongbo Yan et al.

ACS SENSORS (2019)

Review Oncology

Exosome-mediated regulation of tumor immunology

Naohiro Seo et al.

CANCER SCIENCE (2018)

Review Immunology

Role of T cell-derived exosomes in immunoregulation

Jian Lu et al.

IMMUNOLOGIC RESEARCH (2018)

Review Cell Biology

Dendritic cells and routing cargo into exosomes

Dario A. Leone et al.

IMMUNOLOGY AND CELL BIOLOGY (2018)

Editorial Material Biotechnology & Applied Microbiology

Driving T-cell immunotherapy to solid tumors

Ken Garber

NATURE BIOTECHNOLOGY (2018)

Article Oncology

Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges

Dal Fukurnura et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Review Multidisciplinary Sciences

CAR T cell immunotherapy for human cancer

Carl H. June et al.

SCIENCE (2018)

Review Cell Biology

Exosomes in cancer: Use them or target them?

Nuno Bastos et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2018)

Article Pharmacology & Pharmacy

Harnessing albumin as a carrier for cancer therapies

Ella N. Hoogenboezem et al.

ADVANCED DRUG DELIVERY REVIEWS (2018)

Article Immunology

Immunomodulatory Bonds of the Partnership between Dendritic Cells and T Cells

Jessica Bourque et al.

CRITICAL REVIEWS IN IMMUNOLOGY (2018)

Review Biochemistry & Molecular Biology

A Promising Biocompatible Platform: Lipid-Based and Bio-Inspired Smart Drug Delivery Systems for Cancer Therapy

Min Woo Kim et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Review Immunology

Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment

Chunmei Fu et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Oncology

NK Cell-Based Glioblastoma Immunotherapy

Irene Golan et al.

CANCERS (2018)

Article Peripheral Vascular Disease

Macrophage-derived exosomes induce inflammatory factors in endothelial cells under hypertensive conditions

Mayuko Osada-Oka et al.

HYPERTENSION RESEARCH (2017)

Review Immunology

Dendritic cell-based immunotherapy: a basic review and recent advances

Joao Constantino et al.

IMMUNOLOGIC RESEARCH (2017)

Article Oncology

Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells

Peiming Zheng et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2017)

Article Medicine, Research & Experimental

Exosomes Derived From Natural Killer Cells Exert Therapeutic Effect in Melanoma

Liya Zhu et al.

THERANOSTICS (2017)

Article Biochemistry & Molecular Biology

Exosomes: Nanocarriers of Biological Messages

Alice Conigliaro et al.

EXOSOMES IN CARDIOVASCULAR DISEASES: BIOMARKERS, PATHOLOGICAL AND THERAPEUTIC EFFECTS (2017)

Review Immunology

Exosomes carrying immunoinhibitory proteins and their role in cancer

T. L. Whiteside

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2017)

Review Pharmacology & Pharmacy

Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy

Yoshihiro Komohara et al.

ADVANCED DRUG DELIVERY REVIEWS (2016)

Review Medicine, Research & Experimental

Dendritic cell-derived exosomes for cancer therapy

Jonathan M. Pitt et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Biochemistry & Molecular Biology

Prospects for gene-engineered T cell immunotherapy for solid cancers

Christopher A. Klebanoff et al.

NATURE MEDICINE (2016)

Article Multidisciplinary Sciences

Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA

Asako Shimoda et al.

SCIENTIFIC REPORTS (2016)

Review Cell Biology

Biogenesis and Function of T Cell-Derived Exosomes

Leandro N. Ventimiglia et al.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)

Review Biotechnology & Applied Microbiology

Performance-enhancing drugs: design and production of redirected chimeric antigen receptor (CAR) T cells

B. L. Levine

CANCER GENE THERAPY (2015)

Article Chemistry, Multidisciplinary

Using exosomes, naturally-equipped nanocarriers, for drug delivery

Elena V. Batrakova et al.

JOURNAL OF CONTROLLED RELEASE (2015)

Review Cell Biology

Exosomes and their roles in immune regulation and cancer

David W. Greening et al.

SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2015)

Editorial Material Multidisciplinary Sciences

Cancer Immunotherapy

Marcia McNutt

SCIENCE (2013)

Article Immunology

Activated T Cell Exosomes Promote Tumor Invasion via Fas Signaling Pathway

Zhijian Cai et al.

JOURNAL OF IMMUNOLOGY (2012)

Article Medicine, Research & Experimental

A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer

MA Morse et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2005)